Standard & Poor's Corp. lowered its ratings on about $886 million of this drug retailer's debt, expressing particular concern with the company's "willingness to increase leverage."
S&P lowered senior unsecured debt to single-A-minus from single-A.
The company was placed on S&P's CreditWatch list Jan. 7.
S&P said Rite Aid's increased financial risk "is partially offset" by "exceptional operating margins and strong market position in an industry with favorable growth characteristics."
The company recently announced plans to repurchase 22 million common shares, sell noncore operations and close 200 underperforming drugstores.
